Biomarkers in Acute Kidney Injury
Journal of the Korean Society of Pediatric Nephrology
;
: 116-124, 2011.
Artículo
en Coreano
| WPRIM
| ID: wpr-59143
ABSTRACT
Acute kidney injury (AKI) can result in mortality or progress to chronic kidney disease in hospitalized patients. Although serum creatinine has long been used as the best biomarker for diagnosis of AKI, it has some clinical limitations, especially in children. New biomarkers are needed for early diagnosis, differential diagnosis, and reliable prediction of prognosis in AKI. Up to the present, candidate AKI biomarkers include neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), interleukin-18 (IL-18), liver-type fatty acid-binding protein (L-FABP), matrix metalloproteinase-9 (MMP-9), and N-acetyl-beta-D-glucosaminidase (NAG). However, whether these are superior to serum creatinine in the confirmation of diagnosis and prediction of prognosis in AKI is unclear. Further studies are needed for clinical application of these new biomarkers in AKI.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Pronóstico
/
Acetilglucosaminidasa
/
Biomarcadores
/
Interleucina-18
/
Creatinina
/
Metaloproteinasa 9 de la Matriz
/
Diagnóstico Precoz
/
Diagnóstico Diferencial
/
Insuficiencia Renal Crónica
/
Lipocalinas
Tipo de estudio:
Estudio diagnóstico
/
Estudio pronóstico
/
Estudio de tamizaje
Límite:
Niño
/
Humanos
Idioma:
Coreano
Revista:
Journal of the Korean Society of Pediatric Nephrology
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS